UPDATED Mar 31, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GRF | €8.34 | 2.2% | -8.2% | €5.1b | €18.73 | PE95.5x | E29.0% | n/a | Pharmaceuticals & Biotech | ||
ROVI | €80.90 | 0.6% | 109.7% | €4.2b | €75.68 | PE24.6x | E13.1% | 1.4% | Pharmaceuticals & Biotech | ||
ALM | €8.27 | 2.7% | -4.2% | €1.7b | €11.28 | PS1.9x | E47.0% | 2.3% | Pharmaceuticals & Biotech | ||
FAE | €3.15 | -1.3% | -0.6% | €978.9m | €3.71 | PE10.7x | E-1.1% | 4.9% | Pharmaceuticals & Biotech | ||
PHM | €28.74 | 2.5% | -33.6% | €507.0m | €49.40 | PE445.9x | E48.3% | 2.3% | Pharmaceuticals & Biotech | ||
CBAV | €28.30 | -0.4% | 51.7% | €461.4m | n/a | PE12.6x | n/a | 4.6% | Healthcare | ||
ATRY | €3.07 | -2.5% | -41.9% | €232.9m | €6.61 | PS1.1x | E146.4% | n/a | Healthcare | ||
RJF | €2.49 | 0% | -0.4% | €196.2m | €4.10 | PE20.9x | E46.1% | 1.6% | Pharmaceuticals & Biotech | ||
PRM | €10.05 | 0.5% | -7.8% | €171.0m | €16.75 | PE17.5x | S6.5% | 2.6% | Healthcare | ||
ORY | €1.72 | -0.6% | -28.3% | €99.0m | €6.84 | PB1.2x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
PANG | €1.86 | 0% | 8.8% | €54.8m | n/a | PS8.1x | S33.9% | n/a | Pharmaceuticals & Biotech | ||
BST | €0.37 | -0.5% | -24.0% | €21.5m | n/a | PS7.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
LAB | €1.55 | 0% | -50.6% | €11.0m | €2.40 | PB2.4x | E94.2% | n/a | Pharmaceuticals & Biotech | ||
MED | €0.69 | 0% | 88.5% | €8.9m | n/a | PB31.4x | n/a | 0% | Healthcare | ||
IKM | €0.31 | 0% | 0% | €8.3m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
EEP | €0.34 | 0% | -29.2% | €3.7m | n/a | PB0.6x | n/a | n/a | Pharmaceuticals & Biotech |